DGL for Health & Longevity - Quick Reference Sheet

DGL for Health & Longevity

Created on 09/20/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

Licorice root with its sweet, blood-pressure-raising compound largely removed, acting locally on the stomach and oesophageal lining rather than by shutting down acid. Best supported: relief of heartburn, regurgitation and indigestion. Stomach bacterial load falls but is suppressed, not cleared; ulcer healing is conflicted. Products labelled free of the sweet compound often still contain it; potassium carries the harm signal. (Full Review)

Protocol

Standardised extract dose
75 mg twice daily
Trialled over 30 days for functional dyspepsia; 150 mg once daily for 60 days against Helicobacter pylori.
Classic chewable dose
380–800 mg three times daily
Chewed, not swallowed whole. The crossover ulcer trial used 760 mg three times daily for four weeks.
Best time of day
15–20 min before meals
Applies to chewable formats. Capsules of standardised extract were trialled without meal timing.
Time to effect
Reflux & dyspepsia symptoms
7–15 days
Heartburn and regurgitation resolved earlier from day 7 onward.
Further symptom improvement
By day 30
Nothing here acts within hours; symptom trials measured change from day 7.
Helicobacter pylori load
60 days
Bacterial-load reduction only; the trial measured load, not cure.

Benefits

Contraindications
  • Pregnancy at any stage
  • Breastfeeding
  • Uncontrolled hypertension (sustained readings above 140/90 mmHg)
  • Heart failure (New York Heart Association Class III or IV)
  • Documented hypokalaemia (serum potassium below 3.5 mmol/L)
  • Chronic kidney disease (stage 3b or worse, below 45 mL/min/1.73 m²)
  • Primary or secondary hyperaldosteronism, including Conn's syndrome
  • Cirrhosis with ascites
Key Interactions
  • Potassium-wasting diuretics (furosemide, hydrochlorothiazide, chlortalidone)
  • Digoxin
  • Corticosteroids (prednisolone, hydrocortisone, topical steroids)
  • Antihypertensive medication of any class
  • Over-the-counter anti-inflammatory drugs (ibuprofen, naproxen, aspirin)
  • Over-the-counter antacids and alginates
  • Potassium-lowering supplements and foods (high-dose caffeine, whole licorice confectionery, licorice teas)
  • Blood-pressure-lowering supplements (potassium, magnesium, beetroot nitrate, hibiscus)
  • Drugs cleared by CYP3A4 (statins, calcium-channel blockers, ciclosporin)

Risk & Side Effects

  • High: Raised blood pressure, sodium retention and potassium loss
  • Medium: Harm to pregnancy and child development
  • Low: Reduced serum testosterone; cardiac rhythm disturbance in long-term users; nausea and abdominal discomfort
  • Speculative: Oestrogen-receptor activity of licorice flavonoids; forfeiting glycyrrhizin's own systemic effects

Monitoring

Marker Target Why
Serum potassium 4.0–4.5 mmol/L Earliest signal of glycyrrhizin load
Serum sodium 135–142 mmol/L Detects the sodium retention side of the same mechanism
Home blood pressure Below 120/80 mmHg averaged over 7 days The clinical endpoint the risk is defined by
Serum magnesium 2.0–2.4 mg/dL Low magnesium makes potassium loss harder to correct
Plasma renin activity 1.0–3.0 ng/mL/hour, upright Suppression confirms a mineralocorticoid-like load
Serum aldosterone 5–15 ng/dL, upright Falls alongside renin under glycyrrhizin exposure
Estimated glomerular filtration rate 90 mL/min/1.73 m² or above Defines how well potassium can be conserved
Helicobacter pylori stool antigen or urea breath test Negative The endpoint if bacterial load is the goal

Cadence: Home blood pressure daily for the first four weeks, then weekly. Serum potassium and sodium at baseline and four weeks, and again at twelve weeks for anyone continuing beyond a single course or taking diuretics. Kidney function every six to twelve months in continuous users.

Qualitative Assessment

  • Frequency and intensity of heartburn and regurgitation, recorded daily rather than recalled weekly
  • Epigastric pain and upper abdominal fullness after the largest meal of the day
  • Sleep continuity, specifically waking episodes attributable to night-time reflux
  • Unusual muscle weakness, cramping or palpitations, which point towards potassium loss
  • Facial or ankle swelling and unexplained weight gain over days, which point towards sodium retention
  • Whether symptom relief persists in the week after a course ends, which distinguishes mucosal recovery from symptomatic cover